ConductScience.org, home

Gene57787

MARK4: microtubule affinity regulating kinase 4

Cite this record

ConductScience Library. MARK4: microtubule affinity regulating kinase 4. Genes, record 57787. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/57787

FollowSave as evidenceDownload JSON
Sources
13 sources
Release
gene-search-2026-11-13-0.2.1

Gene

Symbol
MARK4
HGNC
Name
microtubule affinity regulating kinase 4
HGNC
NCBI Gene ID
57787
NCBI Gene
HGNC ID
HGNC:13538
HGNC
Ensembl
ENSG00000007047
NCBI Gene
Aliases
FLJ90097, KIAA1860, MARK4L, MARK4S, MARKL1, MARKL1L, Nbla00650, PAR-1D
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q96L34MAP/microtubule affinity-regulating kinase 47522Ensembl, GeneID, HGNC

Source UniProt

Download CSV of proteins

Patents81

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
US 20260193644 A12026-07-091703Q96L34Espacenet
US 20260139247 A12026-05-212552Q96L34Espacenet
JP 2026004568 A2026-01-1452628Q96L34Espacenet
JP 2026000906 A2026-01-06105Q96L34Espacenet
EP 4650780 A22025-11-192132Q96L34Espacenet
EP 4641201 A22025-10-291703Q96L34Espacenet
US 20250320254 A12025-10-162132Q96L34Espacenet
JP 2025529142 A2025-09-042552Q96L34Espacenet
US 12371689 B22025-07-292552Q96L34Espacenet
US 12371689 B22025-07-292552Q96L34Espacenet

See all 81 patentsDownload CSV of patents

NIH grants555

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleMARK4 papersNewest fiscal year
U24AG021886National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)62025
P01CA120964Molecular Pathogenesis of the Hamartoma Syndromes22025
P30AG072980Arizona Alzheimer's Disease Research Center22025
P30CA008748Cancer Center Support Grant22025
P30CA014195Cancer Center Support Grant (CCSG)22025
P30CA016672Cancer Center Support Grant22025
R01AG069900Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models22025
R01NS017950Precursors of Stroke Incidence and Prognosis22025
R01NS115144Genome-Wide Prediction of Dementia in Parkinson's Disease22025
F30AG080885Computational drug repurposing for Alzheimer's disease12025

Source NIH's project files

See all 555 nih grantsDownload CSV of nih grants

Papers561

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Integrated analysis identified MARK4 as a prognostic and immunomodulatory biomarker in oral squamous cell carcinoma.Oncol Lett202642798865PubTator, text miningPubMed
Modeling Synaptic Maturation From Growth Cone to Synapse in Human Organoids.J Neurochem202642108706PubTator, text miningPubMed
Targeting microglia microtubules: cytoskeletal remodeling as a druggable hub in neuroinflammation and neurodegeneration.Front Neurosci202642088827PubTator, text miningPubMed
Targeting of MARK2, but not other MARKs, suppresses TNBC progression by inhibition of the mutant p53-driven signaling pathway.Chin J Nat Med202642019995PubTator, text miningPubMed
Beyond microtubule regulation: the multifaceted roles of tau in neuronal function and dysfunction.Transl Psychiatry202641916933PubTator, text miningPubMed
Programmed cell death: a promising management for Alzheimer's disease.Apoptosis202641904723PubTator, text miningPubMed
Diverse Scaffolds Facilitate NLRP3 Clustering and Inflammasome Formation in Response to Perturbations in Cell Homeostasis.Bioessays202641879501PubTator, text miningPubMed
Discovery of Covalent Ligands with AlphaFold3.J Am Chem Soc202641857796PubTator, text miningPubMed
The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities.MedComm (2020)202641799937PubTator, text miningPubMed
Ligand-Based Pharmacophore Mapping and Virtual Screening for the Search of Biguanide-Like Molecules With Antidiabetic Potentials Targeting Liver Kinase B1.Biochem Res Int202641725923PubTator, text miningPubMed

See all 561 papersDownload CSV of papers

None in this release

  • Drugs
  • Trials

Sources 13

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
  • USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
  • USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/57787

GET https://conductscience.org/api/genes/v1/57787/patents?page=2